Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

GENLISA Influenza B (B/Washington/02/2019, B/Victoria lineage) ELISA

The GENLISA Human Influenza B (B/Washington/02/2019, B/Victoria lineage) ELISA includes features like: - Ready to use protocol with break-apart wells for ease of use - Standardisation and High Reproducibility - Lot to Lot Consistency - Accuracy and Precision Validated against seven points for a "GOLD RING" Standard Quality ELISA - the benchmark sign for Krishgen Quality. The GENLISA ELISA kits are used for assessing the specific biomarker in samples analytes which may be human serum, plasma, biological fluids and cell culture supernatant. The kit uses indirect sandwich assay with double antibodies - capture and detection to ensure a high degree of sensitivity and specificity in the estimation of the biomarker - antigen/antibody. This kit has application for Influenza serology (IgG/total) for immunogenicity studies.

Product Specifications

Short Description

Assay Range: Qualitative | Sensitivity: 30 ng/ml Assay Range: | Sensitivity: Availability: 3 - 4 Weeks | Pack Size: 1 x 96 wells Availability: | Pack Size:

Assay Type

Qualitative

Assay Principle

Sandwich ELISA, Double Antibody

Sample Type

Serum, Plasma, Cell Culture Supernatant, buffer based solutions (pH7.4) and other biological samples.

Sensitivity

30 ng/ml

Shipping Conditions

Shipped at Room Temperature or in gel pack to maintain temperature at 2-8 degrees Celsius

Storage Temperature

The kit (2-8 Degree Celsius) and its components are to be stored as indicated in the IFU (instructions for use) . To ensure quality of your results, if all the wells in the kit are not being used, store the unused wells in the foil pouch containing the desiccant pack, well sealed and store at the indicated temperature. Similary aliquot and store the reconstituted standard at -20 Degree Celsius for long term storage (maximum 6 months from reconstitution) and to avoid deterioration in the activity.

Notes

Vaccine Development :Influenza

Specificity

This assay recognises Influenza B (B/Washington/02/2019, B/Victoria lineage)

Result Type

Quantitative Results Intepretation, 4PL (2nd order) or Cubic Spline Graph. Software (MS Excel) available, on request, to support interpretation of results.
More Discoveries

Explore Other Products

Browse additional items from our catalog

SAMHD1/MOP5 Recombinant Antibody, Cy3 Conjugated
bsm-61737R-Cy3-01 20 µL

SAMHD1/MOP5 Recombinant Antibody, Cy3 Conjugated

Sign In for Pricing
View Details
SAMHD1/MOP5 Recombinant Antibody, Cy3 Conjugated
bsm-61737R-Cy3-02 100 µL

SAMHD1/MOP5 Recombinant Antibody, Cy3 Conjugated

Sign In for Pricing
View Details
CARD15/NOD2 Polyclonal Antibody, AbBy Fluor™ 350 Conjugated
bs-7084R-BF350-01 20 µL

CARD15/NOD2 Polyclonal Antibody, AbBy Fluor™ 350 Conjugated

Sign In for Pricing
View Details
CARD15/NOD2 Polyclonal Antibody, AbBy Fluor™ 350 Conjugated
bs-7084R-BF350-02 100 µL

CARD15/NOD2 Polyclonal Antibody, AbBy Fluor™ 350 Conjugated

Sign In for Pricing
View Details
ZSWIM3 Over-expression Lysate Product
GWB-504AD3 0.1 mg

ZSWIM3 Over-expression Lysate Product

Sign In for Pricing
View Details
UCP2 antibody
FNab09228 100 µg

UCP2 antibody

Sign In for Pricing
View Details